{"SPADE_N_06901": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06901", "Peptide Name": "pAntpâ€“PKI", "Source": "Protein derived", "Family": "", "Gene": "Not found", "Sequence": "RQIKIWFQNRRMKWKKTYADFIASGRTGRRNAI", "Sequence Length": 33, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Rhodamine B", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C184H295N61O44S", "Mass": 4097.76, "PI": 12.0, "Net Charge": 9, "Hydrophobicity": -1.07, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Characterisation of cell-penetrating peptide-mediated peptide delivery.", "Pubmed ID": "15937518", "Reference": "Br J Pharmacol. 2005 Aug;145(8)1093-102.", "Author": "Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SM, Newham P, Lindsay MA.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15937518"}], "Frequent Amino Acids": "RIK", "Absent Amino Acids": "CEHLOPUV", "Basic Residues": 10, "Acidic Residues": 1, "Hydrophobic Residues": 13, "Polar Residues": 21, "Positive Residues": 10, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06878", "Similarity": 1.0, "Sequence": "RQIKIWFQNRRMKWK"}, {"SPADE_ID": "SPADE_N_06939", "Similarity": 1.0, "Sequence": "RQIKIWFQNRRMKW"}, {"SPADE_ID": "SPADE_N_06940", "Similarity": 1.0, "Sequence": "RQIKIWFQNRRMK"}]}}}